A 0 1 0 1 O
history 2 9 2 9 O
of 10 12 10 12 O
allergic 13 21 13 21 O
reactions 22 31 22 31 O
attributed 32 42 32 42 O
to 43 45 43 45 O
compounds 46 55 46 55 O
of 56 58 56 58 O
similar 59 66 59 66 O
chemical 67 75 67 75 O
or 76 78 76 78 O
biologic 79 87 79 87 O
composition 88 99 88 99 O
to 100 102 100 102 O
mitomycin 103 112 103 112 B-allergy_name
C 113 114 113 114 I-allergy_name
or 115 117 115 117 O
other 118 123 118 123 O
agents 124 130 124 130 O
used 131 135 131 135 O
in 136 138 136 138 O
the 139 142 139 142 O
study 143 148 143 148 O

AST(SGOT)/ALT(SGPT 0 18 149 167 B-clinical_variable
) 18 19 167 168 O
≤ 20 21 169 170 O
2.5 22 25 171 174 B-upper_bound
x 26 27 175 176 I-upper_bound
ULN 28 31 177 180 I-upper_bound
, 31 32 180 181 O
alkaline 33 41 182 190 B-clinical_variable
phosphatase 42 53 191 202 I-clinical_variable
≤ 54 55 203 204 O
2.5 56 59 205 208 O
x 60 61 209 210 O
ULN 62 65 211 214 O
, 65 66 214 215 O
unless 67 73 216 222 O
bone 74 78 223 227 B-cancer
metastasis 79 89 228 238 I-cancer
is 90 92 239 241 O
present 93 100 242 249 O
in 101 103 250 252 O
the 104 107 253 256 O
absence 108 115 257 264 O
of 116 118 265 267 O
liver 119 124 268 273 B-cancer
metastasis 125 135 274 284 I-cancer

Absolute 0 8 285 293 B-clinical_variable
neutrophil 9 19 294 304 I-clinical_variable
count 20 25 305 310 I-clinical_variable
≥ 26 27 311 312 O
1,000 28 33 313 318 B-lower_bound
/ 33 34 318 319 I-lower_bound
mcl 34 37 319 322 I-lower_bound

At 0 2 323 325 O
least 3 8 326 331 O
18 9 11 332 334 B-lower_bound
years 12 17 335 340 I-lower_bound
of 18 20 341 343 O
age 21 24 344 347 B-age

Creatinine 0 10 348 358 B-clinical_variable
below 11 16 359 364 O
ULN 17 20 365 368 O
( 21 22 369 370 O
males 22 27 370 375 B-gender
0.7 28 31 376 379 B-lower_bound
- 31 32 379 380 O
1.30 32 36 380 384 B-upper_bound
mg 37 39 385 387 I-upper_bound
/ 39 40 387 388 I-upper_bound
dl 40 42 388 390 I-upper_bound
; 42 43 390 391 O
females 44 51 392 399 B-gender
0.6 52 55 400 403 B-lower_bound
- 55 56 403 404 O
1.10 56 60 404 408 B-upper_bound
mg 61 63 409 411 I-upper_bound
/ 63 64 411 412 I-upper_bound
dl 64 66 412 414 I-upper_bound
) 66 67 414 415 O
OR 68 70 416 418 O
Creatinine 71 81 419 429 B-clinical_variable
clearance 82 91 430 439 I-clinical_variable
≥ 92 93 440 441 O
60 94 96 442 444 B-lower_bound
mL 97 99 445 447 I-lower_bound
/ 99 100 447 448 I-lower_bound
min/1.73 100 108 448 456 I-lower_bound
m2 109 111 457 459 I-lower_bound
for 112 115 460 463 O
patients 116 124 464 472 O
with 125 129 473 477 O
creatinine 130 140 478 488 B-clinical_variable
levels 141 147 489 495 I-clinical_variable
above 148 153 496 501 O
institutional 154 167 502 515 O
normal 168 174 516 522 O

Currently 0 9 523 532 O
receiving 10 19 533 542 O
any 20 23 543 546 O
other 24 29 547 552 O
investigational 30 45 553 568 B-treatment
agents 46 52 569 575 I-treatment

ECOG 0 4 576 580 B-clinical_variable
performance 5 16 581 592 I-clinical_variable
status 17 23 593 599 I-clinical_variable
≤ 24 25 600 601 O
3 26 27 602 603 B-upper_bound

Histologically 0 14 604 618 O
or 15 17 619 621 O
cytologically 18 31 622 635 O
confirmed 32 41 636 645 O
incurable 42 51 646 655 O
HNSCC 52 57 656 661 B-cancer
of 58 60 662 664 O
the 61 64 665 668 O
oral 65 69 669 673 B-cancer
cavity 70 76 674 680 I-cancer
, 76 77 680 681 O
oropharynx 78 88 682 692 B-cancer
, 88 89 692 693 O
larynx 90 96 694 700 B-cancer
, 96 97 700 701 O
hypopharynx 98 109 702 713 B-cancer
, 109 110 713 714 O
and/or 111 117 715 721 O
Level 118 123 722 727 B-lower_bound
1 124 125 728 729 I-lower_bound
- 125 126 729 730 O
3 126 127 730 731 B-upper_bound
neck 128 132 732 736 B-clinical_variable
node 133 137 737 741 I-clinical_variable
with 138 142 742 746 O
non 143 146 747 750 B-cancer
- 146 147 750 751 I-cancer
cutaneous 147 156 751 760 I-cancer
SCC 157 160 761 764 I-cancer
and 161 164 765 768 O
unknown 165 172 769 776 O
primary 173 180 777 784 O

Known 0 5 785 790 O
HIV 6 9 791 794 B-chronic_disease
- 9 10 794 795 O
positivity 10 20 795 805 O
on 21 23 806 808 O
combination 24 35 809 820 B-treatment
antiretroviral 36 50 821 835 I-treatment
therapy 51 58 836 843 I-treatment
because 59 66 844 851 O
of 67 69 852 854 O
the 70 73 855 858 O
potential 74 83 859 868 O
for 84 87 869 872 O
pharmacokinetic 88 103 873 888 O
interactions 104 116 889 901 O
with 117 121 902 906 O
the 122 125 907 910 O
study 126 131 911 916 B-treatment
drugs 132 137 917 922 I-treatment
. 137 138 922 923 O
In 139 141 924 926 O
addition 142 150 927 935 O
, 150 151 935 936 O
these 152 157 937 942 O
patients 158 166 943 951 O
are 167 170 952 955 O
at 171 173 956 958 O
increased 174 183 959 968 O
risk 184 188 969 973 O
of 189 191 974 976 O
lethal 192 198 977 983 O
infections 199 209 984 994 O
when 210 214 995 999 O
treated 215 222 1000 1007 O
with 223 227 1008 1012 O
marrow 228 234 1013 1019 B-treatment
- 234 235 1019 1020 I-treatment
suppressive 235 246 1020 1031 I-treatment
therapy 247 254 1032 1039 I-treatment
. 254 255 1039 1040 O
Appropriate 256 267 1041 1052 O
studies 268 275 1053 1060 O
will 276 280 1061 1065 O
be 281 283 1066 1068 O
undertaken 284 294 1069 1079 O
in 295 297 1080 1082 O
patients 298 306 1083 1091 O
receiving 307 316 1092 1101 O
combination 317 328 1102 1113 O
antiretroviral 329 343 1114 1128 O
therapy 344 351 1129 1136 O
when 352 356 1137 1141 O
indicated 357 366 1142 1151 O

Known 0 5 1152 1157 O
active 6 12 1158 1164 O
central 13 20 1165 1172 B-cancer
nervous 21 28 1173 1180 I-cancer
system 29 35 1181 1187 I-cancer
( 36 37 1188 1189 I-cancer
CNS 37 40 1189 1192 I-cancer
) 40 41 1192 1193 I-cancer
metastases 42 52 1194 1204 I-cancer

Measurable 0 10 1205 1215 O
disease 11 18 1216 1223 O
defined 19 26 1224 1231 O
as 27 29 1232 1234 O
lesions 30 37 1235 1242 O
that 38 42 1243 1247 O
can 43 46 1248 1251 O
be 47 49 1252 1254 O
accurately 50 60 1255 1265 O
measured 61 69 1266 1274 O
in 70 72 1275 1277 O
at 73 75 1278 1280 O
least 76 81 1281 1286 O
one 82 85 1287 1290 O
dimension 86 95 1291 1300 O
( 96 97 1301 1302 O
longest 97 104 1302 1309 O
diameter 105 113 1310 1318 O
to 114 116 1319 1321 O
be 117 119 1322 1324 O
recorded 120 128 1325 1333 O
) 128 129 1333 1334 O
as 130 132 1335 1337 O
≥ 133 134 1338 1339 O
10 135 137 1340 1342 B-lower_bound
mm 138 140 1343 1345 I-lower_bound
with 141 145 1346 1350 O
CT 146 148 1351 1353 B-treatment
scan 149 153 1354 1358 I-treatment
, 153 154 1358 1359 O
as 155 157 1360 1362 O
≥ 158 159 1363 1364 O
20 160 162 1365 1367 B-lower_bound
mm 163 165 1368 1370 I-lower_bound
by 166 168 1371 1373 O
chest 169 174 1374 1379 B-treatment
x 175 176 1380 1381 I-treatment
- 176 177 1381 1382 I-treatment
ray 177 180 1382 1385 I-treatment
, 180 181 1385 1386 O
or 182 184 1387 1389 O
≥ 185 186 1390 1391 O
10 187 189 1392 1394 O
mm 190 192 1395 1397 O
with 193 197 1398 1402 O
calipers 198 206 1403 1411 B-treatment
by 207 209 1412 1414 O
clinical 210 218 1415 1423 O
exam 219 223 1424 1428 O
per 224 227 1429 1432 O
RECIST 228 234 1433 1439 O
1.1 235 238 1440 1443 O

Other 0 5 1444 1449 O
active 6 12 1450 1456 O
malignancy 13 23 1457 1467 B-cancer
with 24 28 1468 1472 O
the 29 32 1473 1476 O
exception 33 42 1477 1486 O
of 43 45 1487 1489 O
basal 46 51 1490 1495 B-cancer
cell 52 56 1496 1500 I-cancer
or 57 59 1501 1503 O
squamous 60 68 1504 1512 B-cancer
cell 69 73 1513 1517 I-cancer
carcinoma 74 83 1518 1527 I-cancer
of 84 86 1528 1530 I-cancer
the 87 90 1531 1534 I-cancer
skin 91 95 1535 1539 I-cancer
which 96 101 1540 1545 O
were 102 106 1546 1550 O
treated 107 114 1551 1558 O
with 115 119 1559 1563 O
local 120 125 1564 1569 O
resection 126 135 1570 1579 O
only 136 140 1580 1584 O
, 140 141 1584 1585 O
carcinoma 142 151 1586 1595 B-cancer
in 152 154 1596 1598 I-cancer
situ 155 159 1599 1603 I-cancer
of 160 162 1604 1606 I-cancer
the 163 166 1607 1610 I-cancer
cervix 167 173 1611 1617 I-cancer
, 173 174 1617 1618 O
or 175 177 1619 1621 O
synchronous 178 189 1622 1633 O
H&N 190 193 1634 1637 O
primaries 194 203 1638 1647 O

Patient 0 7 1648 1655 O
must 8 12 1656 1660 O
have 13 17 1661 1665 O
a 18 19 1666 1667 O
negative 20 28 1668 1676 O
pregnancy 29 38 1677 1686 B-pregnancy
test 39 43 1687 1691 O
within 44 50 1692 1698 O
7 51 52 1699 1700 B-upper_bound
days 53 57 1701 1705 I-upper_bound
of 58 60 1706 1708 O
start 61 66 1709 1714 O
of 67 69 1715 1717 O
study 70 75 1718 1723 B-treatment
treatment 76 85 1724 1733 I-treatment

Platelets 0 9 1734 1743 B-clinical_variable
≥ 10 11 1744 1745 O
75,000 12 18 1746 1752 B-lower_bound
/ 18 19 1752 1753 I-lower_bound
mcl 19 22 1753 1756 I-lower_bound

Pregnant 0 8 1757 1765 B-pregnancy
and/or 9 15 1766 1772 O
breastfeeding 16 29 1773 1786 O

Progression 0 11 1787 1798 O
following 12 21 1799 1808 O
platin 22 28 1809 1815 B-treatment
, 28 29 1815 1816 O
5 30 31 1817 1818 B-treatment
- 31 32 1818 1819 I-treatment
FU 32 34 1819 1821 I-treatment
, 34 35 1821 1822 O
cetuximab 36 45 1823 1832 B-treatment
and 46 49 1833 1836 O
taxane 50 56 1837 1843 B-treatment
given 57 62 1844 1849 O
for 63 66 1850 1853 O
incurable 67 76 1854 1863 O
disease 77 84 1864 1871 O

Subjects 0 8 1872 1880 O
with 9 13 1881 1885 O
previously 14 24 1886 1896 O
treated 25 32 1897 1904 O
brain 33 38 1905 1910 B-cancer
metastases 39 49 1911 1921 I-cancer
may 50 53 1922 1925 O
participate 54 65 1926 1937 O
provided 66 74 1938 1946 O
they 75 79 1947 1951 O
are 80 83 1952 1955 O
stable 84 90 1956 1962 O
( 91 92 1963 1964 O
without 92 99 1964 1971 O
evidence 100 108 1972 1980 O
of 109 111 1981 1983 O
progression 112 123 1984 1995 O
by 124 126 1996 1998 O
imaging 127 134 1999 2006 B-treatment
for 135 138 2007 2010 O
at 139 141 2011 2013 O
least 142 147 2014 2019 O
four 148 152 2020 2024 B-lower_bound
weeks 153 158 2025 2030 I-lower_bound
prior 159 164 2031 2036 I-lower_bound
to 165 167 2037 2039 O
the 168 171 2040 2043 O
first 172 177 2044 2049 O
dose 178 182 2050 2054 O
of 183 185 2055 2057 O
trial 186 191 2058 2063 O
treatment 192 201 2064 2073 B-treatment
and 202 205 2074 2077 O
any 206 209 2078 2081 O
neurologic 210 220 2082 2092 O
symptoms 221 229 2093 2101 O
have 230 234 2102 2106 O
returned 235 243 2107 2115 O
to 244 246 2116 2118 O
baseline 247 255 2119 2127 O
) 255 256 2127 2128 O
, 256 257 2128 2129 O
have 258 262 2130 2134 O
no 263 265 2135 2137 O
evidence 266 274 2138 2146 O
of 275 277 2147 2149 O
new 278 281 2150 2153 O
or 282 284 2154 2156 O
enlarging 285 294 2157 2166 O
brain 295 300 2167 2172 O
metastases 301 311 2173 2183 O
, 311 312 2183 2184 O
and 313 316 2185 2188 O
are 317 320 2189 2192 O
not 321 324 2193 2196 O
using 325 330 2197 2202 O
steroids 331 339 2203 2211 B-treatment
for 340 343 2212 2215 O
at 344 346 2216 2218 O
least 347 352 2219 2224 O
28 353 355 2225 2227 B-lower_bound
days 356 360 2228 2232 I-lower_bound
prior 361 366 2233 2238 I-lower_bound
to 367 369 2239 2241 O
treatment 370 379 2242 2251 O

Total 0 5 2252 2257 B-clinical_variable
bilirubin 6 15 2258 2267 I-clinical_variable
≤ 16 17 2268 2269 O
1.5 18 21 2270 2273 B-upper_bound
mg 22 24 2274 2276 I-upper_bound
/ 24 25 2276 2277 I-upper_bound
dL 25 27 2277 2279 I-upper_bound

Uncontrolled 0 12 2280 2292 O
intercurrent 13 25 2293 2305 B-chronic_disease
illness 26 33 2306 2313 I-chronic_disease
including 34 43 2314 2323 O
, 43 44 2323 2324 O
but 45 48 2325 2328 O
not 49 52 2329 2332 O
limited 53 60 2333 2340 O
to 61 63 2341 2343 O
, 63 64 2343 2344 O
ongoing 65 72 2345 2352 O
or 73 75 2353 2355 O
active 76 82 2356 2362 B-chronic_disease
infection 83 92 2363 2372 I-chronic_disease
, 92 93 2372 2373 O
symptomatic 94 105 2374 2385 O
congestive 106 116 2386 2396 B-chronic_disease
heart 117 122 2397 2402 I-chronic_disease
failure 123 130 2403 2410 I-chronic_disease
, 130 131 2410 2411 O
unstable 132 140 2412 2420 B-chronic_disease
angina 141 147 2421 2427 I-chronic_disease
pectoris 148 156 2428 2436 I-chronic_disease
, 156 157 2436 2437 O
cardiac 158 165 2438 2445 B-chronic_disease
arrhythmia 166 176 2446 2456 I-chronic_disease
, 176 177 2456 2457 O
or 178 180 2458 2460 O
psychiatric 181 192 2461 2472 B-chronic_disease
illness 193 200 2473 2480 I-chronic_disease
/ 200 201 2480 2481 O
social 201 207 2481 2487 B-chronic_disease
situations 208 218 2488 2498 I-chronic_disease
that 219 223 2499 2503 O
would 224 229 2504 2509 O
limit 230 235 2510 2515 O
compliance 236 246 2516 2526 O
with 247 251 2527 2531 O
study 252 257 2532 2537 O
requirements 258 270 2538 2550 O

Women 0 5 2551 2556 B-gender
of 6 8 2557 2559 O
childbearing 9 21 2560 2572 O
potential 22 31 2573 2582 O
and 32 35 2583 2586 O
men 36 39 2587 2590 O
must 40 44 2591 2595 O
agree 45 50 2596 2601 B-contraception_consent
to 51 53 2602 2604 I-contraception_consent
use 54 57 2605 2608 I-contraception_consent
adequate 58 66 2609 2617 I-contraception_consent
contraception 67 80 2618 2631 I-contraception_consent
( 81 82 2632 2633 O
hormonal 82 90 2633 2641 B-contraception_consent
or 91 93 2642 2644 O
barrier 94 101 2645 2652 B-contraception_consent
method 102 108 2653 2659 I-contraception_consent
of 109 111 2660 2662 I-contraception_consent
birth 112 117 2663 2668 I-contraception_consent
control 118 125 2669 2676 I-contraception_consent
, 125 126 2676 2677 O
abstinence 127 137 2678 2688 B-contraception_consent
) 137 138 2688 2689 O
prior 139 144 2690 2695 O
to 145 147 2696 2698 O
study 148 153 2699 2704 O
entry 154 159 2705 2710 O
, 159 160 2710 2711 O
for 161 164 2712 2715 O
the 165 168 2716 2719 O
duration 169 177 2720 2728 O
of 178 180 2729 2731 O
study 181 186 2732 2737 O
participation 187 200 2738 2751 O
, 200 201 2751 2752 O
and 202 205 2753 2756 O
for 206 209 2757 2760 O
1 210 211 2761 2762 B-upper_bound
month 212 217 2763 2768 I-upper_bound
after 218 223 2769 2774 O
completing 224 234 2775 2785 O
treatment 235 244 2786 2795 B-treatment
. 244 245 2795 2796 O
Should 246 252 2797 2803 O
a 253 254 2804 2805 O
woman 255 260 2806 2811 B-gender
become 261 267 2812 2818 O
pregnant 268 276 2819 2827 B-pregnancy
or 277 279 2828 2830 O
suspect 280 287 2831 2838 O
she 288 291 2839 2842 O
is 292 294 2843 2845 O
pregnant 295 303 2846 2854 O
while 304 309 2855 2860 O
participating 310 323 2861 2874 O
in 324 326 2875 2877 O
this 327 331 2878 2882 O
study 332 337 2883 2888 O
, 337 338 2888 2889 O
she 339 342 2890 2893 O
must 343 347 2894 2898 O
inform 348 354 2899 2905 O
her 355 358 2906 2909 O
treating 359 367 2910 2918 O
physician 368 377 2919 2928 O
immediately 378 389 2929 2940 O

